Know Cancer

or
forgot password

Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment


N/A
19 Years
N/A
Not Enrolling
Both
Renal Cancer

Thank you

Trial Information

Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment


Inclusion Criteria:



Retrospective enrollment:

- Patients over 18 years of age

- Patients with renal masses suggestive of malignancy of kidney origin based on biopsy
or imaging criteria

- Patients having undergone percutaneous, open or laparoscopic energy ablation of a
renal mass

- Patients with minimum 2 year renal imaging follow-up, or reasonable expectation that
2 years of renal imaging follow-up can be obtained prospectively

Prospective enrollment:

- Each of the above for patients scheduled to undergo, rather than having undergone,
percutaneous, open or laparoscopic energy ablation of a renal mass.

Exclusion Criteria:

- Patients not having undergone, or considered candidates for percutaneous, open or
laparoscopic energy ablation of a renal mass

- Non-English speaking patients

Type of Study:

Observational [Patient Registry]

Study Design:

Observational Model: Cohort

Outcome Measure:

assess renal ablation outcomes

Outcome Description:

To assess renal ablation outcomes using standard quality of life measures. Specifically, quality of life outcomes measures will be analyzed with respect to ablation procedure characteristics including ablation technique and anesthesia type as well as renal mass characteristics such as size, location and pathologic tumor type.

Outcome Time Frame:

5 years

Safety Issue:

No

Principal Investigator

Jeremy Durack, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

MSKCC 13-116

NCT ID:

NCT01888198

Start Date:

June 2013

Completion Date:

June 2018

Related Keywords:

  • Renal Cancer
  • ablation
  • quality of Life (QOL)
  • kidney
  • registry
  • Ablation of Renal Masses Outcomes Registry (ARMOR)
  • 13-116
  • Carcinoma, Renal Cell
  • Kidney Neoplasms

Name

Location
Memorial Sloan-Kettering Cancer Center New York, New York  10021